(Own report) -Germany and France are seeking greater “European sovereignty” and aim to “strengthen the EU as a geopolitical actor,” according to a Franco-German declaration published yesterday in Paris on the occasion of the ceremonies marking the 60th anniversary of the signing of the Élysée Treaty. The declaration provides military support for Ukraine “for as long as it takes,” announces new armament projects, and a Franco-German exercise in the “Indo-Pacific.” This is also due to Germany's severe setbacks in its rivalry with the Unites States, including its growing military dependence and the threat of its deindustrialization due to the exodus of production sites to the USA. According to the French publicist Emmanuel Todd, the current global power struggle – “the third world war has begun” – is also “about Germany.” German Chancellor Olaf Scholz anticipates the emergence of a “multipolar world,” in which Germany and the EU are to assume leading roles as strong military powers.
· Mounir Satouri (Greens/EFA, EELV) · Jordi Solé i Ferrando (Greens/EFA, Esquerra Republicana de Catalunya) · Diana Riba i Giner
"Germany and Spain have both remained silent publicly on this invitation to join nuclear exercises. However, we are surprised to see that, without any real public debate on the nuclear stakes of this program, they are engaging in an industrial partnership for the FCAS. This Franco-German-Spanish project is the largest armament project of the century. First estimates are of the range of €100 billion of public funds. Already in the 2021-2024 phase (1B), these States will spend €3.5 billion (only for the FCAS); a cost shared equally among them."
Ett nytt franskt utkast till europeisk konfederation i gen. de Gaulles anda, uppenbarligen tillkommet efter brexit; ordf för gruppen : Jean-Pierre Chevènement
1ère Vice-présidente : Marie-Françoise Bechtel, députée de l’Aisne
Vice-présidents : Christian Hutin, député du Nord, Christine Meyer, conseillère régionale des Pays de Loire, Jean-Yves Autexier, ancien parlementaire
Secrétaire générale : Estelle Folest, cadre supérieure
Secrétaire général adjoint : Claude Nicolet, conseiller régional du Nord-Pas-de-Calais
Trésorier : Gérard Pierre, universitaire
Trésorier adjoint : Marie-Pierre Logelin, professeur
In 2007, the European Union adopted a lex specialis, Regulation (EC) No. 1394/2007 on advanced therapy medicinal products (ATMPs), a new legal category of medical product in regenerative medicine. The regulation applies to ATMPs prepared industrially or manufactured by a method involving an industrial process. It also provides a hospital exemption, which means that medicinal products not regulated by EU law do not benefit from a harmonized regime across the European Union but have to respect national laws. This article describes the recent EU laws, and contrasts two national regimes, asking how France and the United Kingdom regulate ATMPs which do and do not fall under the scope of Regulation (EC) No. 1394/2007. What are the different legal categories and their enforceable regimes, and how does the evolution of these highly complex regimes interact with the material world of regenerative medicine and the regulatory bodies and socioeconomic actors participating in it?